X4 Pharmaceuticals's total assets for Q4 2025 were $290.46M, an increase of 77.59% from the previous quarter. XFOR total liabilities were $104.17M for the fiscal quarter, a 2.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.